https://biotechmorning.com/news/orexin-2-agonist-phase-2-milestone-narcolepsy Biotech Morning en 2026-06-18T14:23:57.867Z The Drug That Wakes Up a Sleeping Giant in Neuroscience https://biotechmorning.com/news/gsk-nuvalent-11-billion-oncology-acquisition Biotech Morning en 2026-06-18T14:23:08.267Z GSK Just Bet $11 Billion That It Can Win Lung Cancer https://biotechmorning.com/news/vc-opposes-us-china-biotech-investment-restrictions Biotech Morning en 2026-06-18T14:22:11.412Z The VC Who Told Washington to Back Off China Biotech https://biotechmorning.com/news/olorofim-antifungal-phase-3-results Biotech Morning en 2026-06-18T14:21:24.742Z The First New Class of Antifungal in 20 Years Just Cleared Its Biggest Hurdle https://biotechmorning.com/news/kardigan-myokardia-crew-400-million-ipo Biotech Morning en 2026-06-18T14:20:31.564Z The MyoKardia Crew Is Back, and Wall Street Just Handed Them $400 Million https://biotechmorning.com/news/beam-therapeutics-base-editing-pku-gene-therapy Biotech Morning en 2026-06-18T14:19:39.348Z One Letter in Your DNA Could Ruin Your Life. Beam Wants to Fix It. https://biotechmorning.com/news/jazz-abcellera-4-billion-tce-deal Biotech Morning en 2026-06-18T14:18:43.861Z Jazz Just Wrote a $4 Billion Check for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/biogen-raythera-billion-dollar-immunology-bet Biotech Morning en 2026-06-18T14:17:41.638Z Biogen Just Dropped $1 Billion on a Company Nobody's Heard Of https://biotechmorning.com/news/lilly-acquires-4e-therapeutics-non-opioid-pain Biotech Morning en 2026-06-18T14:16:50.253Z Lilly's $25 Billion Shopping Spree Just Found a Painkiller That Skips the Opioid Problem https://biotechmorning.com/news/oral-carbapenem-tebipenem-fda-approval-uti Biotech Morning en 2026-06-18T14:15:57.094Z The Antibiotic That Finally Escaped the IV Pole https://biotechmorning.com/news/fda-mixed-signals-moderna-mrna-flu-vaccine Biotech Morning en 2026-06-17T14:25:40.176Z The FDA Can't Decide How It Feels About Moderna's Flu Shot https://biotechmorning.com/news/fda-gene-therapy-cheat-code-prior-knowledge Biotech Morning en 2026-06-17T14:24:47.099Z FDA Just Handed Gene Therapy Developers a Cheat Code https://biotechmorning.com/news/medicare-glp1-obesity-coverage-hard-to-undo Biotech Morning en 2026-06-17T14:23:51.849Z Medicare's New Weight-Loss Drug Benefit Has a Built-In Self-Destruct Shield https://biotechmorning.com/news/biontech-curevac-mRNA-acquisition Biotech Morning en 2026-06-17T14:22:55.977Z BioNTech Just Bought Its Biggest Rival for the Price of a Settlement https://biotechmorning.com/news/fda-reversal-uniqure-huntington-gene-therapy Biotech Morning en 2026-06-17T14:22:05.954Z The FDA Said No to This Gene Therapy. Then It Said Yes. Then No. Then… https://biotechmorning.com/news/altaris-simulations-plus-375m-acquisition Biotech Morning en 2026-06-17T14:21:07.162Z Pharma's Favorite Crystal Ball Just Got Bought by Private Equity https://biotechmorning.com/news/failed-trial-ai-goldmine-verge-labs Biotech Morning en 2026-06-17T14:20:12.864Z The Biotech That Turned a Failed Trial Into an AI Goldmine https://biotechmorning.com/news/incyte-vega-therapeutics-von-willebrand-acquisition Biotech Morning en 2026-06-17T14:19:20.038Z Incyte Just Spent $1.25 Billion on a Disease Most People Haven't Heard Of https://biotechmorning.com/news/novo-nordisk-812m-deep-apple-non-incretin-obesity Biotech Morning en 2026-06-17T14:18:27.420Z Novo Nordisk Just Bet $812M That Obesity's Future Isn't GLP-1 https://biotechmorning.com/news/edgewise-hcm-drug-phase-2-data-competition Biotech Morning en 2026-06-17T14:17:30.781Z The Heart Drug That Wants to Beat BMS and Cytokinetics at Their Own Game